Page last updated: 2024-11-06

triethylenemelamine and Polycythemia Vera

triethylenemelamine has been researched along with Polycythemia Vera in 4 studies

Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.

Polycythemia Vera: A myeloproliferative disorder of unknown etiology, characterized by abnormal proliferation of all hematopoietic bone marrow elements and an absolute increase in red cell mass and total blood volume, associated frequently with splenomegaly, leukocytosis, and thrombocythemia. Hematopoiesis is also reactive in extramedullary sites (liver and spleen). In time myelofibrosis occurs.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ELLISON, RR1
GINSBERG, V1
WATSON, J1
ROSENTHAL, N1
ROSENTHAL, RL1
Stecher, G1
Reinhardt, G1

Other Studies

4 other studies available for triethylenemelamine and Polycythemia Vera

ArticleYear
Triethylenemelamine in polycythemia vera; a therapeutic trial.
    Cancer, 1953, Volume: 6, Issue:2

    Topics: Humans; Polycythemia Vera; Triethylenemelamine

1953
Treatment of polycythemia vera with triethylene melamine; summary of thirty cases.
    A.M.A. archives of internal medicine, 1952, Volume: 90, Issue:3

    Topics: Polycythemia Vera; Triethylenemelamine

1952
Chemotherapy in polycythemia vera.
    Acta geneticae medicae et gemellologiae, 1968, Volume: 17, Issue:1

    Topics: Busulfan; Humans; Leukemia; Leukemia, Myeloid; Phosphorus Isotopes; Polycythemia Vera; Primary Myelo

1968
Pipobroman (Vercyte) - a new antineoplastic drug.
    The Medical letter on drugs and therapeutics, 1967, Apr-07, Volume: 9, Issue:7

    Topics: Anemia, Hemolytic; Antineoplastic Agents; Bone Marrow; Busulfan; Chlorambucil; Gastrointestinal Hemo

1967